Compound Detail
CHEMBL4169078
SRA-737 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL4169078 |
| Name | SRA-737 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | YBYYWUUUGCNAHQ-LLVKDONJSA-N |
20
Targets
46
Activities
2
Assay Types
30
PK Parameters
20
Publications
8
Known Names
1
Indications
Molecular Properties
379.4
MW (Da)
1.91
ALogP
8
HBA
3
HBD
107.8
PSA (Ų)
0.72
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Lymphoma, Non-Hodgkin
Activity Summary
IC50 45 meas. best 8.89
EC50 1 meas. best 7.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | IC50 | 8.89 | 8.0393 | 1.3 | 14 |
| MV4-11 CHEMBL613835 | IC50 | 8.37 | 6.97 | 4.3 | 4 |
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | EC50 | 7.52 | 7.52 | 30.0 | 1 |
| Mitogen-activated protein kinase 15 CHEMBL5198 | IC50 | 6.89 | 6.89 | 130.0 | 2 |
| HT-29 CHEMBL384 | IC50 | 6.75 | 6.75 | 176.6 | 1 |
| Serine/threonine-protein kinase D1 CHEMBL3863 | IC50 | 6.53 | 6.53 | 298.0 | 1 |
| Ribosomal protein S6 kinase alpha-1 CHEMBL2553 | IC50 | 6.44 | 6.44 | 362.0 | 2 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | IC50 | 6.44 | 6.44 | 361.0 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 6.24 | 6.0575 | 582.0 | 4 |
| MAP/microtubule affinity-regulating kinase 3 CHEMBL5600 | IC50 | 6.16 | 6.16 | 698.0 | 1 |
| NUAK family SNF1-like kinase 1 CHEMBL5784 | IC50 | 6.15 | 6.15 | 711.0 | 2 |
| Serine/threonine-protein kinase Chk2 CHEMBL2527 | IC50 | 5.9 | 5.755 | 1260.0 | 2 |
| Dual specificity protein kinase CLK2 CHEMBL4225 | IC50 | 5.86 | 5.86 | 1370.0 | 2 |
| Serine/threonine-protein kinase BRSK1 CHEMBL5650 | IC50 | 5.78 | 5.78 | 1660.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
| AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 CHEMBL2111345 | IC50 | 5.53 | 5.53 | 2970.0 | 1 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform CHEMBL4004 | IC50 | 5.46 | 5.46 | 3470.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.42 | 5.42 | 3850.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.21 | 5.21 | 6200.0 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 5.04 | 5.04 | 9030.0 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | IC50 | 4.8 | 4.8 | 15800.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 3770.74 | ng.hr.mL-1 | Mus musculus |
| AUC | 3945.24 | ng.hr.mL-1 | Mus musculus |
| AUC | 99389.7 | ng.hr.mL-1 | Mus musculus |
| AUC | 84215.7 | ng.hr.mL-1 | Mus musculus |
| AUC | 3778.33 | ng.hr.mL-1 | Mus musculus |
| AUC | 3945.24 | ng.hr.mL-1 | Mus musculus |
| AUC | 99389.7 | ng.hr.mL-1 | Mus musculus |
| AUC | 84595.05 | ng.hr.mL-1 | Mus musculus |
| CL | 44.17 | mL.min-1.kg-1 | Mus musculus |
| CL | 58.33 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 35.33 | mL.min-1.kg-1 | Mus musculus |
| CL | 36.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 30100.0 | nM | Mus musculus |
| Cmax | 1620.0 | nM | Mus musculus |
| Cmax | 44700.0 | nM | Mus musculus |
| Cmax | 4000.0 | nM | Mus musculus |
| F | 105.0 | % | Mus musculus |
| F | 38.0 | % | Rattus norvegicus |
| F | 105.0 | % | Mus musculus |
| Fu | 0.0019 | - | Mus musculus |
| Fu | 0.0021 | - | Homo sapiens |
| T1/2 | 2.9 | hr | Mus musculus |
| T1/2 | 2.86 | hr | Mus musculus |
| T1/2 | 2.85 | hr | Mus musculus |
| T1/2 | 2.76 | hr | Mus musculus |
| T1/2 | 3.11 | hr | Mus musculus |
| Tmax | 0.083 | hr | Mus musculus |
| Tmax | 1.0 | hr | Mus musculus |
| Tmax | 0.5 | hr | Mus musculus |
| Tmax | 1.0 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine